Home › Bellerophon Therapeutics Announces Management and Board Additions
 

Keywords :   


Bellerophon Therapeutics Announces Management and Board Additions

2015-07-02 00:40:09| Biotech - Topix.net

Bellerophon Therapeutics, Inc. , a clinical-stage biotherapeutics company, today announced the appointments of Amit Agrawal as Chief Operating Officer, effective July 8, 2015, and Naseem Amin, M.D. as an Independent Director of the Company, effective June 29, 2015. Mr. Agrawal joins Bellerophon from Amgen, Inc., where, since 2012, he served as Director of Strategy and Corporate Development.

Tags: board management additions announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »